secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001640334-23-000800
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience prices public offering of 2.1M units at $0.95/unit for $2.0M gross proceeds
--------------------------------------------------------------------------------

- 2,106,000 units priced at $0.95 each, each unit comprising one share of common stock and one warrant.
- Gross proceeds expected ~$2.0M before fees; warrants exercisable at $0.95 for 5 years.
- Offering expected to close May 11, 2023; Maxim Group LLC sole placement agent.
- Registration statement on Form S-1 (File No. 333-271096) declared effective May 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423000800/0001640334-23-000800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423000800/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-000800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer